share_log

Cantor Fitzgerald Reiterates Overweight on Longboard Pharmaceuticals, Maintains $60 Price Target

Cantor Fitzgerald Reiterates Overweight on Longboard Pharmaceuticals, Maintains $60 Price Target

坎托·菲茨杰拉德重申增持Longboard Pharmicals,维持60美元的目标股价
Moomoo 24/7 ·  04/10 09:42

Cantor Fitzgerald analyst Josh Schimmer reiterates Longboard Pharmaceuticals (NASDAQ:LBPH) with a Overweight and maintains $60 price target.

坎托·菲茨杰拉德分析师乔什·希默重申朗博德制药公司(纳斯达克股票代码:LBPH)增持,目标股价维持60美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发